Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19GlobeNewsWire • 10/06/20
COVID-19 Vaccine Makers AstraZeneca, GSK To Get First Access To Nvidia's 'Cambridge-1' SupercomputerBenzinga • 10/06/20
U.S. federal appeals court reinstates GSK’s £182 million ruling against Teva PharmaceuticalInvezz • 10/04/20
FDA Approves Nucala as the First and Only Biologic Treatment for Hypereosinophilic Syndrome (HES)Business Wire • 09/25/20
Sanofi, GlaxoSmithKline signs deal with Canada to deliver 72 million doses of potential COVID-19 vaccineMarket Watch • 09/22/20
Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccineGlobeNewsWire • 09/22/20
GSK highlights scientific advances across its growing oncology portfolio at ESMO Virtual Congress 2020PRNewsWire • 09/15/20